Abstract: The present invention is directed to a method of selecting animals that are genetically resistant to one or more intestinal parasite infections by testing mucus samples for the presence of an antibody against one or more of said intestinal parasites and segregation and selecting the animals that test positive. The animals that test negative are less parasite resistant and can be subjected to parasite management regimes.
Type:
Application
Filed:
June 12, 2008
Publication date:
September 16, 2010
Applicant:
OVITA LIMITED
Inventors:
Richard John Shaw, Merie Christine Cannon, Sarah Margaret Rosanowski, Mary Wheeler, Christopher Anthony Morris
Abstract: The present invention is related to novel nucleotide sequences encoding a louse allergen and a methods for diagnosing, treating and preventing lice infestation and associated allergic disease with the nucleotide sequences and protein allergen of the invention. The present invention also relates to kits for diagnostic assays.
Type:
Application
Filed:
November 9, 2007
Publication date:
November 20, 2008
Applicant:
OVITA LIMITED
Inventors:
Alexander Terrance Pfeffer, Charles Bix Shoemaker
Abstract: The present invention relates to an isolated monoclonal antibody mAb PAB-1, deposited at ATCC on 24 Jan. 2002 and accorded accession PTA-4005, which binds to a surface antigen on nematode L3. It also relates to the antigen which binds to the monoclonal antibody and uses for the monoclonal antibody and antigen in diagnosing and treating or preventing nematode infection.
Type:
Grant
Filed:
January 30, 2003
Date of Patent:
February 5, 2008
Assignee:
Ovita Limited
Inventors:
Gavin Bernard Lear Harrison, Wayne Robert Hein, Hugh Douglas Pulford, Charles Bix Shoemaker
Abstract: The present invention is related to novel nucleoli sequences encoding a louse allergen and a methods for diagnosing, treating and preventing lice infestation and associated allergic disease with the nucleoli sequences and protein allergen of the invention. The present invention also relates to kits for diagnostic assays.
Type:
Grant
Filed:
April 19, 2001
Date of Patent:
November 13, 2007
Assignee:
Ovita Limited
Inventors:
Alexander Terrance Pfeffer, Charles Bix Shoemaker
Abstract: The present invention relates to a novel promoter sequence which encodes an isolated DNA molecule comprising the polynucleotide sequence of SEQ ID NO: 1 and which encodes the promoter region of the myostatin gene, or a fragment thereof, or variant thereof which has been modified by the insertion, substitution or deletion of one or more nucleotides, said fragment and variant of said polynucleotide sequence having substantially equivalent function thereto.
Type:
Grant
Filed:
July 7, 1999
Date of Patent:
February 7, 2006
Assignee:
Ovita Limited
Inventors:
James J. Bass, Ferenc Jeanplong, Ravi Kambadur, Mridula Sharma
Abstract: The present invention relates to an isolated monoclonal antibody mAb PAB-1, deposited at ATCC on 24 Jan. 2002 and accorded accession PTA-4005, which binds to a surface antigen on nematode L3. It also relates to the antigen which binds to the monoclonal antibody and uses for the monoclonal antibody and antigen in diagnosing and treating or preventing nematode infection.
Type:
Application
Filed:
January 30, 2003
Publication date:
August 18, 2005
Applicants:
OVITA LIMITED, AgResearch Limited
Inventors:
Gavin Harrison, Wayne Hein, Hugh Pulford, Charles Shoemaker